{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-002082","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2023-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.923606+00:00","generated_at":"2026-06-20T12:31:14.518538+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biotricity receives Nasdaq bid price deficiency notice; 180 days to cure","bullets":["Nasdaq letter on Jan 20, 2023: closing bid price below $1.00 for 30 consecutive days.","Company has until July 19, 2023 to regain compliance with Bid Price Rule.","To regain compliance, bid must close at $1.00+ for 10 consecutive business days.","If not compliant by deadline, Nasdaq may delist; company may consider reverse stock split.","No immediate effect on listing or trading of BTCY common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-002082","json":"https://secwatch.observer/filing/0001493152-23-002082.json","markdown":"https://secwatch.observer/filing/0001493152-23-002082.md","text":"https://secwatch.observer/filing/0001493152-23-002082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223002082/0001493152-23-002082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223002082/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:31:14.518538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f12f66afc12282da34cc58a5bf99a7a10b48bd3f","claim":"BIOTRICITY INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"January 20, 2023, Biotricity Inc. (the “Company”), received a letter (the “Letter”) from the staff of The Nasdaq Capital Market LLC (the “NasdaqCapital Market”) stating that the Company’s closing bid price for the last 30 consecutive business days was less than $1.00 per share. As a result, the Company does not satisfy the continued listing requirement to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The notification had no immediate effect on the listing or trading of the common stock on the Nasdaq Capital Market. Nasda","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223002082/0001493152-23-002082-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}